Given that nicotine is an agonist of nAChRs, its chronic exposure may alter receptor sensitivity, potentially offering therapeutic benefits for epilepsy linked to nAChR mutations (34, 36–38). This evidence concerns the gene CHRNA4 and epilepsy.